Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Get concise guidance on balancing a budget amid surprises, including flexible categories and a small emergency cushion.
25,157 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
An Ouster director recently disclosed an open-market sale of thousands of shares. This deep dive explains what such m...
Synopsys posted solid quarterly results but faces Design IP headwinds. The path to a 2027 price target hinges on marg...
For investors seeking reliable, long-term growth in energy, midstream pipelines stand out. Here are three brilliant e...
The AI trade is no longer limited to the chip makers. Dell Technologies, Hewlett Packard Enterprise, and Snowflake ar...
A single indicator could steer the next 12 months for the iShares 20+ Year Treasury Bond ETF (TLT). If the 30-year yi...
Healthcare sector ETFs offer defense and income, but not all are created equal. This article dives into how state str...
A $1,000 investment in QUALCOMM in 2011 could have grown significantly by 2026, driven by a pivot from smartphones to...
XRP sunk to a four-month low just under $1.15 as whale activity and ETF dynamics shift the supply-demand balance. Ana...
Fidelity has alerted owners of 500-stock funds that the S&P 500 is dominated by a small group of mega-caps, raising q...
June 2026’s crypto rout erased about $62 billion in market value from public firms with Bitcoin on the balance sheet,...
Silicon Valley’s long-running belief that technology could change the world is fading as market realities and politic...